Learn about our new 5-letter sequencing technology – duet multiomics solution +modC – and discover the combinatorial power of genetics and epigenetics.
PMWC provides valuable insights for physicians and others wondering how close we are to realizing the arrival of personalized medicine. The conferences are helpful in understanding where and how the envelope is being pushed.
Ph.D., Global Head of Business Development and Customer Solutions, biomodal
biomodal
Liquid biopsy for profiling cell-free DNA holds promise to transform how we manage cancer by early detection and identification of residual disease and subtype. biomodal’s duet multiomics solution +modC generates data from low input amounts, obtains more sensitive somatic variant calling, and obtains multimodal information to discriminate cancer patients from healthy controls.
